Molecular Oxygen Modulates Cytochrome c Oxidase Function*
- § To whom correspondence should be addressed: Dept. of Medicine, The University of Chicago, MC 6026, 5841 South Maryland Ave., Chicago, IL 60637. Tel.: 312-702-6790; Fax: 312-702-4736. E-mail: pschumac{at}medicine.bsd.uchicago.edu
Abstract
This study sought to determine whether molecular oxygen interacts with cytochrome c oxidase to modify its catalytic activity. Such an interaction could explain the observation that mitochondria incubated under low O2 concentrations exhibit a reversible suppression of State 3 respiration. Oxidized bovine heart cytochrome c oxidase was incubated in oxygen concentrations of <50 μM for 4 h. The enzyme exhibited a reversible decrease in Vmax after incubation, compared with control enzyme incubated at higher oxygen concentrations. This change was accompanied by a small increase in the apparent Km of the enzyme for both cytochrome c and oxygen, although the optical absorption spectra of oxidized, cycling, or reduced enzyme were not affected. Spectroscopy studies after 4 h of incubation revealed that heme a3 was 33% reduced during cycling at [O2] = 25 μM whereas enzyme at [O2] = 135 μM was only 18% reduced, suggesting that the site of inhibition occurred at the electron transfer step between heme a3 and O2. These results provide a mechanistic explanation for the observation that intact cells or mitochondria exhibit a reversible inhibition of respiration during prolonged exposure to [O2] <25 mM, by demonstrating that the catalytic activity of cytochrome c oxidase function is similarly inhibited, possibly through an allosteric effect of molecular O2 on the enzyme.
Footnotes
-
↵‡ Supported in part by an American Heart Association Senior Fellowship Award.
-
↵* This work was supported by NHLBI Grants HL32646 and HL35440. The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
-
↵1 The abbreviation used is:
- TMPD
-
N,N,N′,N′-tetramethyl-p-phenylenediamine.
-
- Received March 5, 1996.
- Revision received April 26, 1996.
- © 1996 by The American Society for Biochemistry and Molecular Biology, Inc.











